Dedicated Clinical Research Coordinator experienced in complying with study protocols, standard operating procedures and good clinical practices. A research professional proficient in handling patient information, laboratory samples and compliance procedures for diverse clinical trials. Highly organized with excellent communication and planning skills
Bavarian Nordic
A Randomized, Double-Blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN-RSV Vaccine in Adults ≥60 years of Age
Sanofi US Services Inc.
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and Older
UCB Biopharma SRL
A PHASE 1/2A, RANDOMIZED,PLACEBO-CONTROLLED, SINGLE-ASCENDING DOSE(PART A,PARTICIPANT-AND INVESTIGATOR-BLIND) AND REPEAT-DOSE (PART B, PARTICIPANT-,INVESTIGATOR-, AND SPONSOR-BLIND) STUDY TOINVESTIGATE THE SAFETY, PHARMACOKINETICS,AND EFFICACY (PART B ONLY) OF UCB1381 INHEALTHY STUDY PARTICIPANTS (PART A) AND INSTUDY PARTICIPANTS WITH MODERATE TOSEVERE ATOPIC DERMATITIS (PART B)
Highlightll
A randomized, double-blinded, placebo-controlled, multicenter Phase 2 study evaluating the efficacy and safety of TLL018 in participants with moderate-to-severe plaque psoriasis
Cara Therapuetics
A 2 part, Multicenter, Randomize, Double-blind Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate-to-Sever Pruritus in Adults Subjects with Notalgia Paresthetica
AstraZeneca
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
Ionis Pharmaceuticals Inc.
A Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study of Olezarsen (ISIS 678354) in Patients with Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), or with Severe Hypertriglyceridemia